FDA Approves Generic Drug for Relapsing Multiple Sclerosis


Original post, click here
Share this...
Tweet about this on TwitterShare on FacebookShare on LinkedInEmail this to someoneShare on Google+Share on RedditPin on Pinterest

Officials with the FDA have approved Novartis’ glatiramer acetate injection (Glatopa) 40-mg/mL for the treatment of multiple sclerosis (MS).